CTCBIO Inc. (KOSDAQ:060590)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,705.00
-190.00 (-4.88%)
At close: Apr 2, 2026
Market Cap88.58B -46.2%
Revenue (ttm)123.77B +3.2%
Net Income3.24B
EPS136.00
Shares Out23.91M
PE Ratio27.02
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume65,943
Average Volume63,967
Open3,935.00
Previous Close3,895.00
Day's Range3,650.00 - 3,935.00
52-Week Range3,635.00 - 7,680.00
Beta-0.11
RSI36.87
Earnings DateMar 27, 2026

About CTCBIO

CTCBIO Inc. provides various pharmaceutical products in South Korea and internationally. The company offers animal and human pharmaceuticals; feed additives and ingredients; and functional food products. It also provides cardiovascular, gastrointestinal, osteoporosis, antibiotic, smoking cessation, antifungal and antiviral, antiepileptic, allergic rhinitis, dermatology and genito-urinory, allergic rhinitis and antihistamine, neuropsychiarty, intestinal disorders, X-ray, diabetes, anti-inflammatory and arthritis, and harmones, as well as CTC cov... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1993
Employees 248
Stock Exchange KOSDAQ
Ticker Symbol 060590
Full Company Profile

Financial Performance

Financial Statements